Article
[Molecular diagnostics of lung cancer].
Magyar onkologia - 1 Sept 2015
Ryska A, Dziadziuszko R, Olszewski W, Berzinec P, Öz B, Gottfried M, Cufer T, Samarzija M, Plank L, Ostoros Gy, Tímár J
Abstract excerpt
Development of the target therapies of lung cancer was a rapid process which fundamentally changed the pathological diagnosis as well. Furthermore, molecular pathology became essential part of the routine diagnostics of lung cancer. These changes generated several practical problems and in underdeveloped countries or in those with reimbursement problems have been combined with further challenges. The central and...
Topics
- Anaplastic Lymphoma Kinase
- Carcinoma, Non-Small-Cell Lung
- Consensus
- ErbB Receptors
- Europe
- Gene Rearrangement
- Humans
- Lung Neoplasms
- Molecular Targeted Therapy
- Mutation
- Pathology, Molecular